ZCM
BSX icon

Zenyatta Capital Management’s Boston Scientific BSX Stock Holding History

Zenyatta Capital Management’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-50,000
Closed -$2.89M – 23
2023
Q4 		$2.89M Sell
50,000
-90,000
-64% -$4.8M 1.12% 21
2023
Q3 		$7.39M Buy
+140,000
New +$7.34M 4.01% 9
2023
Q2 		– Sell
-40,000
Closed -$2M – 30
2023
Q1 		$2M Sell
40,000
-70,000
-64% -$3.3M 2.15% 12
2022
Q4 		$5.09M Buy
+110,000
New +$4.76M 2.84% 14

Other funds holding BSX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Zenyatta Capital Management's BSX Position: Q1 2024 in Review

Zenyatta Capital Management sold out of Boston Scientific (BSX) in Q1 2024, closing a stake of 50,000 shares — an estimated $2.89M sold.

Zenyatta Capital Management first reported a position in BSX in Q4 2022 and held it in 4 quarters. The position peaked at $7.39M in Q3 2023. 1,222 funds tracked by Wall St. Rank hold BSX as of Q1 2024.

  • Zenyatta Capital Management reported no remaining Boston Scientific position as of Q1 2024 after selling out during the quarter.
  • Zenyatta Capital Management sold 50,000 Boston Scientific shares in Q1 2024, an estimated $2.89M.
  • Zenyatta Capital Management first reported a position in Boston Scientific in Q4 2022 and held it in 4 quarters.
  • Zenyatta Capital Management's Boston Scientific position peaked at $7.39M in Q3 2023.
  • 1,222 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2024.

Based on Zenyatta Capital Management's 13F filing for Q1 2024, filed 17 Apr 2024.